[go: up one dir, main page]

GB9723061D0 - Medicaments - Google Patents

Medicaments

Info

Publication number
GB9723061D0
GB9723061D0 GBGB9723061.9A GB9723061A GB9723061D0 GB 9723061 D0 GB9723061 D0 GB 9723061D0 GB 9723061 A GB9723061 A GB 9723061A GB 9723061 D0 GB9723061 D0 GB 9723061D0
Authority
GB
United Kingdom
Prior art keywords
medicaments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9723061.9A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Ligand UK Development Ltd
Original Assignee
SmithKline Beecham Ltd
Vanguard Medica Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd, Vanguard Medica Ltd filed Critical SmithKline Beecham Ltd
Priority to GBGB9723061.9A priority Critical patent/GB9723061D0/en
Publication of GB9723061D0 publication Critical patent/GB9723061D0/en
Priority to ZA9809890A priority patent/ZA989890B/xx
Priority to PCT/GB1998/003234 priority patent/WO1999022730A1/fr
Priority to AU96373/98A priority patent/AU9637398A/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB9723061.9A 1997-10-31 1997-10-31 Medicaments Ceased GB9723061D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GBGB9723061.9A GB9723061D0 (en) 1997-10-31 1997-10-31 Medicaments
ZA9809890A ZA989890B (en) 1997-10-31 1998-10-29 Medicaments.
PCT/GB1998/003234 WO1999022730A1 (fr) 1997-10-31 1998-10-29 Utilisation de (+)-6-carboxamido-3-methylamino-1,2,3,4-tetrahydrocarbazole pour le traitement de l'hyperalgie
AU96373/98A AU9637398A (en) 1997-10-31 1998-10-29 Use of (+)-6-carboxamido-3-methylamino-1,2,3,4-tetrahydrocarbazole for treating hyperalgesia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9723061.9A GB9723061D0 (en) 1997-10-31 1997-10-31 Medicaments

Publications (1)

Publication Number Publication Date
GB9723061D0 true GB9723061D0 (en) 1998-01-07

Family

ID=10821408

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9723061.9A Ceased GB9723061D0 (en) 1997-10-31 1997-10-31 Medicaments

Country Status (4)

Country Link
AU (1) AU9637398A (fr)
GB (1) GB9723061D0 (fr)
WO (1) WO1999022730A1 (fr)
ZA (1) ZA989890B (fr)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9113802D0 (en) * 1991-06-26 1991-08-14 Smithkline Beecham Plc Medicaments
GB9226530D0 (en) * 1992-12-21 1993-02-17 Smithkline Beecham Plc Compounds
AU2243897A (en) * 1996-01-17 1997-08-11 Eli Lilly And Company Methods of treating or preventing pain or nociception
AU2434297A (en) * 1996-05-23 1997-12-09 Alcon Laboratories, Inc. The use of 5-ht1b/1d agonists to treat ocular pain

Also Published As

Publication number Publication date
WO1999022730A1 (fr) 1999-05-14
ZA989890B (en) 2000-05-02
AU9637398A (en) 1999-05-24

Similar Documents

Publication Publication Date Title
GB9721139D0 (en) Medicaments
GB9606805D0 (en) Medicaments
GB9611947D0 (en) Medicaments
GB9618974D0 (en) Medicaments
GB9702021D0 (en) Medicaments
GB9718791D0 (en) Medicaments
GB9605293D0 (en) Medicaments
GB2320900B (en) Inhalers
GB9611167D0 (en) Medicaments
GB9828620D0 (en) Medicaments
GB9613096D0 (en) Medicaments
GB9723506D0 (en) Medicaments
GB9700908D0 (en) Medicaments
GB9723061D0 (en) Medicaments
GB9703045D0 (en) Medicaments
GB9702132D0 (en) Medicaments
GB9700323D0 (en) Combined medicaments
GB2329335B (en) Medicament
GB9726234D0 (en) Medicament
GB9702946D0 (en) Medicament
GB0002424D0 (en) Medicament
GB9605329D0 (en) Medicaments
GB9605859D0 (en) Medicaments
GB9618975D0 (en) Medicaments
GB9623160D0 (en) Medicaments

Legal Events

Date Code Title Description
COOA Change in applicant's name or ownership of the application
AT Applications terminated before publication under section 16(1)